BMC Psychiatry

official impact factor 2.89

Open Access Highly Access Research article

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Douglas Faries, Haya Ascher-Svanum*, Baojin Zhu, Christoph Correll and John Kane

BMC Psychiatry 2005, 5:26 doi:10.1186/1471-244X-5-26

No comments have yet been made on this article.

Post a comment